The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Q4 2024 Management View CEO Paul Sarvadi highlighted that adjusted EPS for Q4 2024 was $0.05, with adjusted EBITDA at $23 million, surpassing the midpoint of expectations. Paid worksite employees ...

Sees Q1 revenue $185M, consensus $221.59M. Executive Vice President and CFO Jamie Coogan said, “We are pleased with our financial execution in ...

Reports Q4 revenue $252.4M, consensus $244.95M. President and CEO Russell Low commented, “Axcelis (ACLS) exited the year on a strong note, with ...

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Walt Disney surprised analysts with a strong first-quarter performance, driven by an uptick in its direct-to-consumer segment ...

Cloudflare reported earnings that not only beat analyst estimates but also exceeded its own forecasts, highlighting robust ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...

Yum China Holdings, Inc. (NYSE:YUMC) shares are trading higher on Thursday after the fourth-quarter FY24 earnings result. The ...

Snapchat (SNAP) reported its Q4 2024 earnings results today, posting beats on both earnings per share (EPS) and revenue ...

Putting everything together with the new stimulus plans announced in China, IQ appears quite undervalued at close to 4x 2027 EPS. Under my own DCF model, I also observed significant upside ...

AMD’s Q4 2024 earnings report was released at the close of markets today. The tech company reported $7.7 billion in revenue, ...